# Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin

> **NCT03699332** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 29 (estimated)

## Conditions studied

- Peritoneal Carcinomatosis
- Colorectal Cancer
- Carcinoma
- Neoplasms
- Gastrointestinal Cancer

## Interventions

- **DRUG:** Indium-111-DOTA-Labetuzumab-IRDye800CW injection
- **RADIATION:** SPECT/CT scan
- **PROCEDURE:** CRS extended with dual-modality imaging

## Key facts

- **NCT ID:** NCT03699332
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-09
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2019-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03699332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03699332, "Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03699332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*